Baxter International, Inc. (BAX)
26.13
+0.20
(+0.77%)
USD |
NYSE |
Aug 28, 16:00
26.12
-0.01
(-0.04%)
After-Hours: 20:00
Baxter International Cash from Operations (Quarterly) : 285.00M for June 30, 2026
Cash from Operations (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 285.00M |
| March 31, 2026 | 213.00M |
| December 31, 2025 | 584.00M |
| September 30, 2025 | 237.00M |
| June 30, 2025 | 217.00M |
| March 31, 2025 | -193.00M |
| December 31, 2024 | 488.00M |
| September 30, 2024 | 253.00M |
| June 30, 2024 | 115.00M |
| March 31, 2024 | 163.00M |
| December 31, 2023 | 531.00M |
| September 30, 2023 | 365.00M |
| June 30, 2023 | 351.00M |
| March 31, 2023 | 479.00M |
| December 31, 2022 | 439.00M |
| September 30, 2022 | 290.00M |
| June 30, 2022 | 274.00M |
| March 31, 2022 | 208.00M |
| December 31, 2021 | 693.00M |
| September 30, 2021 | 675.00M |
| June 30, 2021 | 477.00M |
| March 31, 2021 | 377.00M |
| December 31, 2020 | 712.00M |
| September 30, 2020 | 510.00M |
| June 30, 2020 | 374.00M |
| Date | Value |
|---|---|
| March 31, 2020 | 272.00M |
| December 31, 2019 | 829.00M |
| September 30, 2019 | 701.00M |
| June 30, 2019 | 446.00M |
| March 31, 2019 | 128.00M |
| December 31, 2018 | 709.00M |
| September 30, 2018 | 456.00M |
| June 30, 2018 | 405.00M |
| March 31, 2018 | 447.00M |
| December 31, 2017 | 514.00M |
| September 30, 2017 | 605.00M |
| June 30, 2017 | 529.00M |
| March 31, 2017 | 189.00M |
| December 31, 2016 | 713.00M |
| September 30, 2016 | 499.00M |
| June 30, 2016 | 775.00M |
| March 31, 2016 | -333.00M |
| December 31, 2015 | 724.00M |
| September 30, 2015 | 255.00M |
| June 30, 2015 | 696.00M |
| March 31, 2015 | 96.00M |
| December 31, 2014 | 1.143B |
| September 30, 2014 | 914.00M |
| June 30, 2014 | 599.00M |
| March 31, 2014 | 559.00M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Becton, Dickinson & Co. | 652.00M |
| DexCom, Inc. | 269.20M |
| Boston Scientific Corp. | 1.474B |
| West Pharmaceutical Services, Inc. | 124.00M |
| Abbott Laboratories | 2.488B |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -117.00M |
| Cash from Financing (Quarterly) | -31.00M |
| Free Cash Flow | 812.00M |
| Free Cash Flow Per Share (Quarterly) | 0.3205 |
| Free Cash Flow to Equity (Quarterly) | 996.00M |
| Free Cash Flow to Firm (Quarterly) | 230.08M |
| Free Cash Flow Yield | 6.03% |